Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity.

Cite

CITATION STYLE

APA

Krajner, F., Hadaya, L., McQueen, G., Sendt, K. V., Gillespie, A., Avila, A., … Egerton, A. (2022). Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia. Schizophrenia, 8(1). https://doi.org/10.1038/s41537-022-00230-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free